首页 > 最新文献

AIDS Research and Treatment最新文献

英文 中文
Incidence and Predictors of Opportunistic Infection Among People Living With HIV in Ethiopia: A Systematic Review and Meta-Analysis. 埃塞俄比亚艾滋病毒感染者机会性感染的发病率和预测因素:系统回顾和荟萃分析。
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2026-01-31 eCollection Date: 2026-01-01 DOI: 10.1155/arat/7249878
Beyene Zewdu Nigatu, Amhasilasie Ewunetu Ageze

Background: Opportunistic infections (OIs) play a crucial role in the morbidity and mortality of HIV-infected individuals. Despite the increasing use of antiretroviral therapy, there remains a lack of comprehensive data on the incidence of OIs to provide a clearer national picture. Therefore, this systematic review and meta-analysis aim to determine the pooled incidence and identify the predictors of OIs among people living with HIV in Ethiopia.

Method: A systematic search was conducted across multiple electronic databases to identify relevant studies. The degree of heterogeneity across studies was assessed using the I 2 statistic. Subgroup analyses were conducted to explore sources of heterogeneity. A funnel plot and Egger's test were used to assess publication bias. Adjusted hazard ratio with 95% CI was used to assess the relationship between predictors and OIs occurrence.

Result: In total, 24 studies met the inclusion criteria and were analyzed. The pooled incidence rate of OIs among people living with HIV in Ethiopia was found to be 6.96 per 100 person-years (95% CI: 5.14-8.78) based on a random-effects model. The meta-analysis identified predictors of OIs among people living with HIV, including poor adherence (pooled AHR 1.42, 95% CI: 1.12, 1.80), CD4 count < 200 cells/mm3 (AHR 1.49, 95% CI: 1.25, 1.78), being bedridden (AHR 1.45, 95% CI: 1.10, 1.90), and advanced WHO clinical stage (AHR 1.57, 95% CI: 1.24, 1.98).

Conclusion: The burden of OIs continues to be a major health concern among people living with HIV/AIDS. Low CD4 count, poor adherence to ART, being bedridden, and advanced clinical stage were significantly associated with the occurrence of OIs.

背景:机会性感染(OIs)在hiv感染者的发病率和死亡率中起着至关重要的作用。尽管越来越多地使用抗逆转录病毒疗法,但仍然缺乏关于oi发病率的全面数据,无法提供更清晰的全国情况。因此,本系统综述和荟萃分析旨在确定埃塞俄比亚艾滋病毒感染者的总发病率,并确定OIs的预测因素。方法:系统检索多个电子数据库,查找相关研究。使用i2统计量评估各研究的异质性程度。进行亚组分析以探索异质性的来源。采用漏斗图和Egger检验评估发表偏倚。采用95% CI的校正风险比来评估预测因子与OIs发生之间的关系。结果:共有24项研究符合纳入标准并进行了分析。根据随机效应模型,埃塞俄比亚艾滋病毒感染者的oi总发病率为6.96 / 100人年(95% CI: 5.14-8.78)。荟萃分析确定了艾滋病毒感染者中OIs的预测因素,包括依从性差(汇总AHR 1.42, 95% CI: 1.12, 1.80)、CD4 3计数(AHR 1.49, 95% CI: 1.25, 1.78)、卧床(AHR 1.45, 95% CI: 1.10, 1.90)和晚期WHO临床阶段(AHR 1.57, 95% CI: 1.24, 1.98)。结论:oi的负担仍然是艾滋病毒/艾滋病感染者的一个主要健康问题。CD4计数低、抗逆转录病毒治疗依从性差、卧床不起、临床分期较晚与OIs的发生显著相关。
{"title":"Incidence and Predictors of Opportunistic Infection Among People Living With HIV in Ethiopia: A Systematic Review and Meta-Analysis.","authors":"Beyene Zewdu Nigatu, Amhasilasie Ewunetu Ageze","doi":"10.1155/arat/7249878","DOIUrl":"10.1155/arat/7249878","url":null,"abstract":"<p><strong>Background: </strong>Opportunistic infections (OIs) play a crucial role in the morbidity and mortality of HIV-infected individuals. Despite the increasing use of antiretroviral therapy, there remains a lack of comprehensive data on the incidence of OIs to provide a clearer national picture. Therefore, this systematic review and meta-analysis aim to determine the pooled incidence and identify the predictors of OIs among people living with HIV in Ethiopia.</p><p><strong>Method: </strong>A systematic search was conducted across multiple electronic databases to identify relevant studies. The degree of heterogeneity across studies was assessed using the <i>I</i> <sup>2</sup> statistic. Subgroup analyses were conducted to explore sources of heterogeneity. A funnel plot and Egger's test were used to assess publication bias. Adjusted hazard ratio with 95% CI was used to assess the relationship between predictors and OIs occurrence.</p><p><strong>Result: </strong>In total, 24 studies met the inclusion criteria and were analyzed. The pooled incidence rate of OIs among people living with HIV in Ethiopia was found to be 6.96 per 100 person-years (95% CI: 5.14-8.78) based on a random-effects model. The meta-analysis identified predictors of OIs among people living with HIV, including poor adherence (pooled AHR 1.42, 95% CI: 1.12, 1.80), CD4 count < 200 cells/mm<sup>3</sup> (AHR 1.49, 95% CI: 1.25, 1.78), being bedridden (AHR 1.45, 95% CI: 1.10, 1.90), and advanced WHO clinical stage (AHR 1.57, 95% CI: 1.24, 1.98).</p><p><strong>Conclusion: </strong>The burden of OIs continues to be a major health concern among people living with HIV/AIDS. Low CD4 count, poor adherence to ART, being bedridden, and advanced clinical stage were significantly associated with the occurrence of OIs.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2026 ","pages":"7249878"},"PeriodicalIF":1.8,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12860221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the HIV Case-Based Surveillance System in Dire Dawa City Administration, Ethiopia. A Descriptive Cross-Sectional Study. 对埃塞俄比亚迪勒达瓦市政府基于病例的艾滋病毒监测系统的评价。一项描述性横断面研究。
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2026-01-23 eCollection Date: 2026-01-01 DOI: 10.1155/arat/6539109
Fitsum Hagos, Aklesiya Kassahun, Ashenafi Sisay

Background: Ethiopia started the human immunodeficiency virus (HIV) case-based surveillance (CBS) system along with Research Electronic Data Capture (REDCap) in June 2021. From January to June 2022, only five out of 14 CBS implementing health facilities in Dire Dawa City, Ethiopia, reported 35 newly diagnosed HIV patients through the REDCap Database compared to 314 in the District Health Information System (DHIS-2). This study aimed to evaluate the CBS system, its usefulness, and reasons for underreporting in Dire Dawa City, Ethiopia.

Methods: We used a descriptive cross-sectional study design. We customized the data collection tools from the Centers for Disease Control and Prevention (CDC), a guideline for evaluating public health surveillance systems. Questionnaires were administered to 36 healthcare workers involved in supporting CBS. Completed HIV CBS case reporting forms were also assessed for completeness. EPI Info software was used for data entry and analysis. Descriptive statistics, such as frequencies and proportions, were used to describe the findings.

Results: Interviews were successfully conducted with 34 health workers. The lack of CBS reporting guidelines for healthcare facilities was 22 (61%). Limited coordination between technical staff and health facilities 19 (53%) and limited competency in REDCap 23 (64%) were also observed. CBS data timeliness, completeness, and validity were 89%, 87%, and 99%, respectively, in the REDCap. There is a lack of standard operating procedures during system interruption. The overall health facility representativeness was 368 of 757 (49%). Acceptability was 100%, mainly due to reduced paperwork and the ability to generate simple reports.

Conclusion: and Recommendations: The HIV CBS system was timely and acceptable. However, its representativeness was poor owing to limited competency in the REDCap. We recommend that health workers receive further training for case-based HIV surveillance.

背景:埃塞俄比亚于2021年6月启动了基于人类免疫缺陷病毒(HIV)病例的监测(CBS)系统以及研究电子数据捕获(REDCap)。2022年1月至6月,埃塞俄比亚迪拉达瓦市14个哥伦比亚广播公司实施的卫生设施中,只有5个通过REDCap数据库报告了35名新诊断的艾滋病毒患者,而在地区卫生信息系统(DHIS-2)中报告了314名。本研究旨在评估埃塞俄比亚迪勒达瓦市哥伦比亚广播公司(CBS)系统、其实用性以及低报的原因。方法:采用描述性横断面研究设计。我们从疾病控制和预防中心(CDC)定制了数据收集工具,这是评估公共卫生监测系统的指南。对参与支持CBS的36名医护人员进行问卷调查。还评估了完成的艾滋病毒CBS病例报告表格的完整性。使用EPI Info软件进行数据录入和分析。描述性统计,如频率和比例,被用来描述这些发现。结果:成功地对34名卫生工作者进行了访谈。22个国家(61%)缺乏针对医疗机构的CBS报告指南。还观察到技术人员与卫生机构19之间的协调有限(53%),REDCap 23的能力有限(64%)。在REDCap中,CBS数据的及时性、完整性和有效性分别为89%、87%和99%。在系统中断期间缺乏标准操作程序。757个卫生机构中有368个具有总体代表性(49%)。可接受性是100%,主要是由于减少了文书工作和生成简单报告的能力。结论和建议:HIV CBS系统是及时和可接受的。然而,由于REDCap的能力有限,其代表性较差。我们建议卫生工作者接受基于病例的艾滋病毒监测方面的进一步培训。
{"title":"Evaluation of the HIV Case-Based Surveillance System in Dire Dawa City Administration, Ethiopia. A Descriptive Cross-Sectional Study.","authors":"Fitsum Hagos, Aklesiya Kassahun, Ashenafi Sisay","doi":"10.1155/arat/6539109","DOIUrl":"10.1155/arat/6539109","url":null,"abstract":"<p><strong>Background: </strong>Ethiopia started the human immunodeficiency virus (HIV) case-based surveillance (CBS) system along with Research Electronic Data Capture (REDCap) in June 2021. From January to June 2022, only five out of 14 CBS implementing health facilities in Dire Dawa City, Ethiopia, reported 35 newly diagnosed HIV patients through the REDCap Database compared to 314 in the District Health Information System (DHIS-2). This study aimed to evaluate the CBS system, its usefulness, and reasons for underreporting in Dire Dawa City, Ethiopia.</p><p><strong>Methods: </strong>We used a descriptive cross-sectional study design. We customized the data collection tools from the Centers for Disease Control and Prevention (CDC), a guideline for evaluating public health surveillance systems. Questionnaires were administered to 36 healthcare workers involved in supporting CBS. Completed HIV CBS case reporting forms were also assessed for completeness. EPI Info software was used for data entry and analysis. Descriptive statistics, such as frequencies and proportions, were used to describe the findings.</p><p><strong>Results: </strong>Interviews were successfully conducted with 34 health workers. The lack of CBS reporting guidelines for healthcare facilities was 22 (61%). Limited coordination between technical staff and health facilities 19 (53%) and limited competency in REDCap 23 (64%) were also observed. CBS data timeliness, completeness, and validity were 89%, 87%, and 99%, respectively, in the REDCap. There is a lack of standard operating procedures during system interruption. The overall health facility representativeness was 368 of 757 (49%). Acceptability was 100%, mainly due to reduced paperwork and the ability to generate simple reports.</p><p><strong>Conclusion: </strong>and Recommendations: The HIV CBS system was timely and acceptable. However, its representativeness was poor owing to limited competency in the REDCap. We recommend that health workers receive further training for case-based HIV surveillance.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2026 ","pages":"6539109"},"PeriodicalIF":1.8,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12828580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146054453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Two Anti-HIV-1 Regimens on Creatinine and Blood Lipids in Elderly People Living With HIV-1. 两种抗HIV-1方案对老年HIV-1感染者肌酐和血脂的影响
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2026-01-06 eCollection Date: 2026-01-01 DOI: 10.1155/arat/6185559
Peipei Luo, Juan Jin, Jinling Yin, Dingsheng Kong, Haohua Hou, Guoxiang Yang, Huanhuan Ba, Jiajia Li

Background: Elderly people living with HIV-1 (PLWH) are more prone to HIV-related complications.

Methods: We investigated the creatinine and blood lipids of 153 PLWHs receiving an ANV regimen and 315 PLWHs receiving an EFV regimen.

Results: The results showed that the abnormal rates of creatinine were very low in both groups, and ANV had a lower triglycerides abnormality than EFV. No evident difference in high-density lipoprotein, low-density lipoprotein, and total cholesterol was observed between the two groups. The abnormal body mass index of the ANV group aged 66 and above was much less than that of the EFV group.

Conclusion: Both the ANV and EFV regimens did not cause severe kidney damage. ANV had an advantage in controlling dyslipidemia. We strongly recommend elderly PLWHs to choose the ANV regimen.

背景:老年HIV-1感染者(PLWH)更容易发生hiv相关并发症。方法:对153例接受ANV治疗的PLWHs和315例接受EFV治疗的PLWHs进行了肌酐和血脂的测定。结果:两组肌酐异常率均很低,ANV组甘油三酯异常率低于EFV组。两组间高密度脂蛋白、低密度脂蛋白、总胆固醇无明显差异。66岁及以上ANV组异常体质指数明显低于EFV组。结论:ANV和EFV方案均未引起严重的肾损害。ANV在控制血脂异常方面具有优势。我们强烈建议老年PLWHs选择ANV方案。
{"title":"Effects of Two Anti-HIV-1 Regimens on Creatinine and Blood Lipids in Elderly People Living With HIV-1.","authors":"Peipei Luo, Juan Jin, Jinling Yin, Dingsheng Kong, Haohua Hou, Guoxiang Yang, Huanhuan Ba, Jiajia Li","doi":"10.1155/arat/6185559","DOIUrl":"10.1155/arat/6185559","url":null,"abstract":"<p><strong>Background: </strong>Elderly people living with HIV-1 (PLWH) are more prone to HIV-related complications.</p><p><strong>Methods: </strong>We investigated the creatinine and blood lipids of 153 PLWHs receiving an ANV regimen and 315 PLWHs receiving an EFV regimen.</p><p><strong>Results: </strong>The results showed that the abnormal rates of creatinine were very low in both groups, and ANV had a lower triglycerides abnormality than EFV. No evident difference in high-density lipoprotein, low-density lipoprotein, and total cholesterol was observed between the two groups. The abnormal body mass index of the ANV group aged 66 and above was much less than that of the EFV group.</p><p><strong>Conclusion: </strong>Both the ANV and EFV regimens did not cause severe kidney damage. ANV had an advantage in controlling dyslipidemia. We strongly recommend elderly PLWHs to choose the ANV regimen.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2026 ","pages":"6185559"},"PeriodicalIF":1.8,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12771633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Retention in Care and Factors Associated With Antiretroviral Therapy Among People Living With HIV in the Upper West Region of Ghana: A Retrospective Cohort Study. 评估加纳上西部地区艾滋病毒感染者的护理保留率和抗逆转录病毒治疗相关因素:一项回顾性队列研究
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/arat/8819023
Henry Ping-Naah, Stephen Ayisi Addo, Ekow Wiah, Marijanatu Abdulai, Kwadwo Owusu, Damien Punguyire, Shamwill Issah, Bismark Sarfo

Background: Antiretroviral therapy (ART) programs that retain people living with HIV (PLWH) in care are essential for maintaining viral suppression, improving health outcomes, and halting the spread of HIV. While ART accessibility has improved, retention in care is still low in Ghana. Although several factors account for this, there are limited data to support it. This study assessed the factors influencing retention in care of PLWH in the Upper West Region (UWR) of Ghana.

Method: The study used a retrospective cohort design to track 482 PLWH who started ART in 2019 across 14 ART clinics in the UWR of Ghana. Demographic, clinical, and psychological elements linked to retention were accessed by extracting data from the HIV electronic tracker database. The characteristics of the study participants summarized using descriptive statistics, estimates of retention rates, and relationships between presumed predictors and retention were obtained through Cox proportional hazards regression and Kaplan-Meier survival analysis.

Results: The results demonstrate that 384/482 (79.7%) participants remained in care at 6 months, 354/482(73.4%) at 12 months, 298/482 (61.8%) at 24 months, and 260/482 (53.9%) at 36 months, indicating a decline in ART retention with time. Age, HIV status disclosure, and viral load suppression are important determinants of retention. Older ages between 50 and 79 years (HR = 0.29, 95% CI: 0.13-0.61) have a 71% reduced risk of attrition compared with younger age groups. Psychosocial factors were positively associated with retention as the HIV status disclosure had HR = 0.50 (95% CI: 0.29-0.88). The unknown viral load status significantly increased the risk of attrition (HR = 6.41, 95% CI: 4.50-9.12).

Conclusion: This study has demonstrated that retention rates decrease with time and that retention was significantly predicted by age and viral load status, with better retention rates shown in older PLWH and those aware of their viral load status.

背景:使艾滋病毒感染者(PLWH)得到护理的抗逆转录病毒治疗(ART)规划对于维持病毒抑制、改善健康结果和阻止艾滋病毒传播至关重要。虽然抗逆转录病毒治疗的可及性有所改善,但在加纳,接受治疗的人数仍然很低。虽然有几个因素可以解释这一点,但支持这一观点的数据有限。本研究评估了影响加纳上西部地区(UWR) PLWH护理留置的因素。方法:该研究采用回顾性队列设计,追踪加纳UWR 14家ART诊所于2019年开始ART治疗的482名PLWH。通过从艾滋病毒电子跟踪数据库中提取数据,可以访问与保留有关的人口统计学、临床和心理因素。通过描述性统计总结研究参与者的特征,估计保留率,并通过Cox比例风险回归和Kaplan-Meier生存分析获得推定预测因素与保留率之间的关系。结果:随访6个月时,384/482例(79.7%)患者仍在治疗,12个月时,354/482例(73.4%),24个月时,298/482例(61.8%),36个月时,260/482例(53.9%),表明ART保留率随时间下降。年龄,艾滋病毒状态披露和病毒载量抑制是保留的重要决定因素。年龄在50至79岁之间的老年人(HR = 0.29, 95% CI: 0.13-0.61)与年轻年龄组相比,减员风险降低了71%。社会心理因素与HIV状态披露呈正相关,HR = 0.50 (95% CI: 0.29-0.88)。未知的病毒载量状态显著增加了磨损的风险(HR = 6.41, 95% CI: 4.50-9.12)。结论:本研究表明,保留率随着时间的推移而下降,保留率与年龄和病毒载量状态有显著关系,年龄较大的PLWH和知道自己病毒载量状态的PLWH的保留率更高。
{"title":"Assessing Retention in Care and Factors Associated With Antiretroviral Therapy Among People Living With HIV in the Upper West Region of Ghana: A Retrospective Cohort Study.","authors":"Henry Ping-Naah, Stephen Ayisi Addo, Ekow Wiah, Marijanatu Abdulai, Kwadwo Owusu, Damien Punguyire, Shamwill Issah, Bismark Sarfo","doi":"10.1155/arat/8819023","DOIUrl":"10.1155/arat/8819023","url":null,"abstract":"<p><strong>Background: </strong>Antiretroviral therapy (ART) programs that retain people living with HIV (PLWH) in care are essential for maintaining viral suppression, improving health outcomes, and halting the spread of HIV. While ART accessibility has improved, retention in care is still low in Ghana. Although several factors account for this, there are limited data to support it. This study assessed the factors influencing retention in care of PLWH in the Upper West Region (UWR) of Ghana.</p><p><strong>Method: </strong>The study used a retrospective cohort design to track 482 PLWH who started ART in 2019 across 14 ART clinics in the UWR of Ghana. Demographic, clinical, and psychological elements linked to retention were accessed by extracting data from the HIV electronic tracker database. The characteristics of the study participants summarized using descriptive statistics, estimates of retention rates, and relationships between presumed predictors and retention were obtained through Cox proportional hazards regression and Kaplan-Meier survival analysis.</p><p><strong>Results: </strong>The results demonstrate that 384/482 (79.7%) participants remained in care at 6 months, 354/482(73.4%) at 12 months, 298/482 (61.8%) at 24 months, and 260/482 (53.9%) at 36 months, indicating a decline in ART retention with time. Age, HIV status disclosure, and viral load suppression are important determinants of retention. Older ages between 50 and 79 years (HR = 0.29, 95% CI: 0.13-0.61) have a 71% reduced risk of attrition compared with younger age groups. Psychosocial factors were positively associated with retention as the HIV status disclosure had HR = 0.50 (95% CI: 0.29-0.88). The unknown viral load status significantly increased the risk of attrition (HR = 6.41, 95% CI: 4.50-9.12).</p><p><strong>Conclusion: </strong>This study has demonstrated that retention rates decrease with time and that retention was significantly predicted by age and viral load status, with better retention rates shown in older PLWH and those aware of their viral load status.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"8819023"},"PeriodicalIF":1.8,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12714114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. BIKSWITCH研究:病毒学抑制hiv感染患者从非整合酶抑制剂治疗转向比替格拉韦/恩曲他滨/替诺福韦Alafenamide (B/F/TAF)的有效性和安全性
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.1155/arat/8818830
Fernando Pérez-Calvo, Francisco Jover-Diaz, Elisabet Delgado-Sánchez, Jorge Peris-García, María Ángeles Bernabéu-Martínez

Objectives: Beyond initial antiretroviral therapy (ART), bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg (B/F/TAF) has been evaluated as an option for the continuation of treatment for virologically suppressed individuals who switch from other regimens. While treatment-emergent resistance to bictegravir has not been observed in clinical trials, rare case reports have described resistance development during B/F/TAF therapy, typically in the context of suboptimal adherence. Its favourable safety profile, minimal drug-drug interactions and proven virological efficacy suggest that virologically suppressed individuals may benefit from switching to B/F/TAF.

Methods: Descriptive, retrospective, observational study of adults with HIV infection receiving effective non-INSTI (integrase strand transfer inhibitors)-based ART who switched to a B/F/TAF, but not all were suppressed. We compared individuals' viral loads, CD4+ lymphocyte counts, glomerular filtration rates, and lipid profiles before the switch and after 24 weeks of B/F/TAF. Safety was also assessed.

Results: Seventy-nine individuals switched from non-INSTI-based therapies to B/F/TAF. At 24 weeks after the switch, HIV-1 RNA < 50 copies/mL was reported in 96.1% and 92.4% of participants per protocol and intention-to-treat analysis, respectively, compared to 81.0% at baseline. This represents a 15.1% increase in virologic suppression (viral load < 50 copies/mL) compared to baseline. No significant changes were detected in the CD4+ lymphocyte count, glomerular filtration rate, or lipid profile. Adverse events (AEs) were reported in 5.1% of patients. Three patients discontinued treatment due to AEs.

Conclusions: The results of this study suggest that patients can switch to B/F/TAF from non-INSTI-based therapies without compromising the effectiveness or safety of ART.

目的:除了初始抗逆转录病毒治疗(ART)之外,比替格拉韦/恩曲他滨/替诺福韦阿拉那胺50/200/25 mg (B/F/TAF)已被评估为从其他方案转换的病毒学抑制个体的继续治疗选择。虽然在临床试验中尚未观察到治疗引起的比替格拉韦耐药,但罕见的病例报告描述了B/F/TAF治疗期间耐药的发展,通常是在次优依从性的情况下。其良好的安全性、最小的药物-药物相互作用和已证实的病毒学疗效表明,病毒学抑制的个体可能从改用B/F/TAF中受益。方法:描述性、回顾性、观察性研究,接受有效的非整合酶链转移抑制剂(insti)为基础的抗逆转录病毒治疗的成人HIV感染患者,他们转换为B/F/TAF,但并非所有人都受到抑制。我们比较了在B/F/TAF治疗前和24周后个体的病毒载量、CD4+淋巴细胞计数、肾小球滤过率和脂质谱。安全性也进行了评估。结果:79名患者从非基于inist的治疗转为B/F/TAF。结论:这项研究的结果表明,患者可以从非基于inri的治疗转向B/F/TAF,而不会影响ART的有效性和安全性。
{"title":"BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients.","authors":"Fernando Pérez-Calvo, Francisco Jover-Diaz, Elisabet Delgado-Sánchez, Jorge Peris-García, María Ángeles Bernabéu-Martínez","doi":"10.1155/arat/8818830","DOIUrl":"10.1155/arat/8818830","url":null,"abstract":"<p><strong>Objectives: </strong>Beyond initial antiretroviral therapy (ART), bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg (B/F/TAF) has been evaluated as an option for the continuation of treatment for virologically suppressed individuals who switch from other regimens. While treatment-emergent resistance to bictegravir has not been observed in clinical trials, rare case reports have described resistance development during B/F/TAF therapy, typically in the context of suboptimal adherence. Its favourable safety profile, minimal drug-drug interactions and proven virological efficacy suggest that virologically suppressed individuals may benefit from switching to B/F/TAF.</p><p><strong>Methods: </strong>Descriptive, retrospective, observational study of adults with HIV infection receiving effective non-INSTI (integrase strand transfer inhibitors)-based ART who switched to a B/F/TAF, but not all were suppressed. We compared individuals' viral loads, CD4+ lymphocyte counts, glomerular filtration rates, and lipid profiles before the switch and after 24 weeks of B/F/TAF. Safety was also assessed.</p><p><strong>Results: </strong>Seventy-nine individuals switched from non-INSTI-based therapies to B/F/TAF. At 24 weeks after the switch, HIV-1 RNA < 50 copies/mL was reported in 96.1% and 92.4% of participants per protocol and intention-to-treat analysis, respectively, compared to 81.0% at baseline. This represents a 15.1% increase in virologic suppression (viral load < 50 copies/mL) compared to baseline. No significant changes were detected in the CD4+ lymphocyte count, glomerular filtration rate, or lipid profile. Adverse events (AEs) were reported in 5.1% of patients. Three patients discontinued treatment due to AEs.</p><p><strong>Conclusions: </strong>The results of this study suggest that patients can switch to B/F/TAF from non-INSTI-based therapies without compromising the effectiveness or safety of ART.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"8818830"},"PeriodicalIF":1.8,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12699972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Factors Influencing Antiretroviral Therapy (ART) Nonadherence in Men During Different Stages of the Life Course: A Case Study in Greater Gaborone, Botswana. 男性不同生命阶段抗逆转录病毒治疗(ART)不依从的患病率和影响因素:博茨瓦纳大哈博罗内的案例研究
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-12-11 eCollection Date: 2025-01-01 DOI: 10.1155/arat/5711642
Matlhogonolo Kelepile, Sue C Grady

Background: Adult men living with HIV are less likely than women to adhere to antiretroviral therapy (ART). This highlights the need to understand factors driving nonadherence and how adherence behaviors and barriers change with age. However, existing HIV surveillance data often collapse ages into broad groups, limiting life-course analysis. This study addresses this gap by examining the time from HIV diagnosis to ART initiation and subsequent adherence barriers among men, using women as a comparison group, in Greater Gaborone, Botswana. To explore these dynamics, we employed a cross-sectional survey design tailored to capture age-specific patterns of ART initiation and adherence.

Methods: A cross-sectional survey was conducted with a stratified random sample of 239 men and 428 women attending 21 HIV treatment clinics. Semistructured questionnaires captured life-course characteristics, including the stage of HIV disease at ART initiation and individual-level factors affecting adherence.

Results: The results showed that men (n = 239) initiated ART medication during Stage 1 (n = 165, 61.9%), early Stage 2 (n = 46, 19.2%), late Stage 2 (n = 17, 7.1%), and Stage 3 (n = 11, 4.6%). Most men (69.1%) were diagnosed in Stage 1 of HIV disease compared to early Stage 2 (19.2%), late Stage 2 (7.1%), and Stage 3 (4.6%). Majority of the men (n = 63, 38.2%) diagnosed in Stage 1 were aged 40-49 years, followed by those aged 30-39 years (n = 38, 23.0%). ART nonadherence rates were 46.0% for men and 29.1% for women. Men who were more likely to be ART nonadherent (compared to women) were aged 30-39 years (OR = 2.05, 1.06-3.56), 40-49 years (OR = 1.91, 1.06-3.45), and 50+ years (OR = 3.95, 1.73-8.97). Other risk factors for ART nonadherence were recently sick, comorbidities, and taking other medications.

Conclusion: Despite free ART and medical care in Botswana, men face barriers related to comorbidities, highlighting the need for targeted gender-specific interventions to improve ART adherence.

背景:感染艾滋病毒的成年男性坚持抗逆转录病毒治疗(ART)的可能性低于女性。这突出了了解不依从性的驱动因素以及依从性行为和障碍如何随年龄变化的必要性。然而,现有的艾滋病毒监测数据往往将年龄分解为广泛的群体,限制了生命过程的分析。本研究在博茨瓦纳大哈博罗内以妇女为对照组,通过检查男性从艾滋病毒诊断到开始抗逆转录病毒治疗的时间和随后的依从性障碍,解决了这一差距。为了探索这些动态,我们采用了一项横断面调查设计,旨在捕捉ART开始和坚持的年龄特定模式。方法:采用横断面调查方法,对21家艾滋病治疗诊所的239名男性和428名女性进行分层随机抽样。半结构式问卷收集了生命历程特征,包括开始抗逆转录病毒治疗时的艾滋病毒疾病阶段和影响依从性的个人层面因素。结果:男性(n = 239)在1期(n = 165,占61.9%)、2期早期(n = 46,占19.2%)、2期晚期(n = 17,占7.1%)和3期(n = 11,占4.6%)开始ART治疗。大多数男性(69.1%)被诊断为艾滋病毒疾病的第一阶段,而第二阶段早期(19.2%)、第二阶段晚期(7.1%)和第三阶段(4.6%)。诊断为第一阶段的男性以40-49岁(n = 63, 38.2%)居多,其次为30-39岁(n = 38, 23.0%)。ART不依从率男性为46.0%,女性为29.1%。与女性相比,30-39岁(OR = 2.05, 1.06-3.56)、40-49岁(OR = 1.91, 1.06-3.45)和50岁以上(OR = 3.95, 1.73-8.97)的男性更容易出现ART非依从性。抗逆转录病毒治疗不依从的其他危险因素是最近生病、合并症和服用其他药物。结论:尽管博茨瓦纳提供免费的抗逆转录病毒治疗和医疗服务,但男性仍面临与合并症相关的障碍,这突出表明需要有针对性的针对性别的干预措施,以改善抗逆转录病毒治疗的依从性。
{"title":"Prevalence and Factors Influencing Antiretroviral Therapy (ART) Nonadherence in Men During Different Stages of the Life Course: A Case Study in Greater Gaborone, Botswana.","authors":"Matlhogonolo Kelepile, Sue C Grady","doi":"10.1155/arat/5711642","DOIUrl":"10.1155/arat/5711642","url":null,"abstract":"<p><strong>Background: </strong>Adult men living with HIV are less likely than women to adhere to antiretroviral therapy (ART). This highlights the need to understand factors driving nonadherence and how adherence behaviors and barriers change with age. However, existing HIV surveillance data often collapse ages into broad groups, limiting life-course analysis. This study addresses this gap by examining the time from HIV diagnosis to ART initiation and subsequent adherence barriers among men, using women as a comparison group, in Greater Gaborone, Botswana. To explore these dynamics, we employed a cross-sectional survey design tailored to capture age-specific patterns of ART initiation and adherence.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted with a stratified random sample of 239 men and 428 women attending 21 HIV treatment clinics. Semistructured questionnaires captured life-course characteristics, including the stage of HIV disease at ART initiation and individual-level factors affecting adherence.</p><p><strong>Results: </strong>The results showed that men (<i>n</i> = 239) initiated ART medication during Stage 1 (<i>n</i> = 165, 61.9%), early Stage 2 (<i>n</i> = 46, 19.2%), late Stage 2 (<i>n</i> = 17, 7.1%), and Stage 3 (<i>n</i> = 11, 4.6%). Most men (69.1%) were diagnosed in Stage 1 of HIV disease compared to early Stage 2 (19.2%), late Stage 2 (7.1%), and Stage 3 (4.6%). Majority of the men (<i>n</i> = 63, 38.2%) diagnosed in Stage 1 were aged 40-49 years, followed by those aged 30-39 years (<i>n</i> = 38, 23.0%). ART nonadherence rates were 46.0% for men and 29.1% for women. Men who were more likely to be ART nonadherent (compared to women) were aged 30-39 years (OR = 2.05, 1.06-3.56), 40-49 years (OR = 1.91, 1.06-3.45), and 50+ years (OR = 3.95, 1.73-8.97). Other risk factors for ART nonadherence were recently sick, comorbidities, and taking other medications.</p><p><strong>Conclusion: </strong>Despite free ART and medical care in Botswana, men face barriers related to comorbidities, highlighting the need for targeted gender-specific interventions to improve ART adherence.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"5711642"},"PeriodicalIF":1.8,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12696395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements and Challenges in Eliminating Perinatal Transmission of HIV in Sub-Saharan Africa: A Comprehensive Analysis. 在消除艾滋病毒在撒哈拉以南非洲围产期传播的进展和挑战:综合分析。
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-11-30 eCollection Date: 2025-01-01 DOI: 10.1155/arat/8894456
George Baah, Stephen T Odonkor

UNAIDS estimated that in 2023, 84% of pregnant women living with HIV were receiving antiretroviral therapy (ART) for the Prevention of Perinatal Transmission of HIV (PPT-HIV), potentially averting up to 220,000 new HIV infections in newborns. However, despite the scale-up of PPT-HIV services, approximately 160,000 children became infected with HIV in 2022 alone. This underscores the urgent need to refocus efforts on addressing the challenges of PPT-HIV to ensure that sub-Saharan Africa meets global targets for eliminating new perinatal transmission. This article examines interventions that have demonstrated positive impacts on PPT-HIV services and recommends their implementation in areas where they are needed. Among these interventions is the critical importance of enhancing community-based test-and-treat initiatives for people of childbearing age and improving access to prenatal care, HIV testing and ART for expectant mothers. Additionally, there is a need to emphasise the role of technology and involve male partners in PPT-HIV programmes to enhance effectiveness and achieve the desired outcomes.

联合国艾滋病规划署估计,到2023年,84%感染艾滋病毒的孕妇正在接受抗逆转录病毒治疗,以预防艾滋病毒围产期传播,可能避免多达22万例新生儿新感染艾滋病毒。然而,尽管扩大了预防艾滋病毒治疗服务,仅在2022年就有约16万名儿童感染艾滋病毒。这突出表明,迫切需要将工作重点重新放在应对艾滋病毒产后感染的挑战上,以确保撒哈拉以南非洲实现消除新的围产期传播的全球目标。本文审查了已证明对预防艾滋病毒治疗服务有积极影响的干预措施,并建议在需要的地区实施这些干预措施。在这些干预措施中,至关重要的是加强以社区为基础的育龄人口检测和治疗举措,并改善孕妇获得产前护理、艾滋病毒检测和抗逆转录病毒治疗的机会。此外,有必要强调技术的作用,并让男性伙伴参与预防艾滋病毒方案,以提高效率并实现预期的结果。
{"title":"Advancements and Challenges in Eliminating Perinatal Transmission of HIV in Sub-Saharan Africa: A Comprehensive Analysis.","authors":"George Baah, Stephen T Odonkor","doi":"10.1155/arat/8894456","DOIUrl":"10.1155/arat/8894456","url":null,"abstract":"<p><p>UNAIDS estimated that in 2023, 84% of pregnant women living with HIV were receiving antiretroviral therapy (ART) for the Prevention of Perinatal Transmission of HIV (PPT-HIV), potentially averting up to 220,000 new HIV infections in newborns. However, despite the scale-up of PPT-HIV services, approximately 160,000 children became infected with HIV in 2022 alone. This underscores the urgent need to refocus efforts on addressing the challenges of PPT-HIV to ensure that sub-Saharan Africa meets global targets for eliminating new perinatal transmission. This article examines interventions that have demonstrated positive impacts on PPT-HIV services and recommends their implementation in areas where they are needed. Among these interventions is the critical importance of enhancing community-based test-and-treat initiatives for people of childbearing age and improving access to prenatal care, HIV testing and ART for expectant mothers. Additionally, there is a need to emphasise the role of technology and involve male partners in PPT-HIV programmes to enhance effectiveness and achieve the desired outcomes.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"8894456"},"PeriodicalIF":1.8,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145655698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drivers of Utilization of HIV Self-Test Among Males in Malawi: A Multilevel Analysis of the Multiple Indicator Cluster Survey 2019-2020. 马拉维男性使用艾滋病毒自检的驱动因素:2019-2020年多指标聚类调查的多层次分析
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-11-09 eCollection Date: 2025-01-01 DOI: 10.1155/arat/5527525
Thokozani Mzumara, Yamikani Matewere, Mayamiko Mbamba, Chisomo White, Aaron Chidothe, Lazarus Obed Livingstone Banda, Grace Ogbonna, George Munthali, Rita Soko, Mlotha Mbughi, James Mkandawire

Background: Implementation of health programs often overlooks males compared to females, and this is true even for HIV programs. Most men do not visit hospitals, and this is where, for example, most of the HIV services are delivered, including HIV testing. Self-testing can help men know their HIV status and possibly prevent the spread and increase treatment uptake.

Aim: This study aimed to assess the utilization of HIV self-testing among males in Malawi and its predictors.

Methods: This paper utilizes secondary quantitative data from the 2019-2020 Multiple Indicator Cluster Survey (MICS). The study sample included 7750 males aged 15 to 49. Data analysis used the Chi-square test to show the association between self-testing and rural/urban residence, region, radio-listenership, internet use, prior testing history, and educational level. Then, a multilevel binary logistic regression analysis was done to show the effect of predictor variables on the outcome reporting on the fixed and random effects, including the odds ratio, 95% confidence interval, and intraclass correlation coefficient. Statistical significance was determined at the p < 0.05 level.

Results: Approximately 10% of males have ever used an HIV self-test. The logistic regression model indicated that ever used the internet (OR = 1.535, CI: [1.231, 1.9150], p < 0.05), ever tested for HIV (OR = 0.181, CI: [0.122, 0.268], p < 0.001), rural residence (OR = 0.493, CI: [0.349, 0.698], p < 0.001), and region (OR = 3.619, CI: [2.120, 6.178], p < 0.001).

Conclusion: The study confirms that HIVST is affected by several sociodemographic factors, calling for targeted interventions to improve HIVST among males.

背景:与女性相比,卫生项目的实施往往忽视了男性,即使是艾滋病毒项目也是如此。大多数男子不去医院,而医院是提供包括艾滋病毒检测在内的大多数艾滋病毒服务的地方。自我检测可以帮助男性了解自己的艾滋病毒状况,并可能防止传播和增加治疗。目的:本研究旨在评估马拉维男性艾滋病毒自检的使用情况及其预测因素。方法:利用2019-2020年多指标类集调查(MICS)的二次定量数据。研究样本包括7750名年龄在15至49岁之间的男性。数据分析采用卡方检验显示自测与城乡居住、地区、广播听众、互联网使用、先前测试历史和教育水平之间的关系。然后,进行多水平二元logistic回归分析,以显示预测变量对固定效应和随机效应结果报告的影响,包括优势比、95%置信区间和类内相关系数。在p < 0.05水平上有统计学意义。结果:大约10%的男性曾经进行过艾滋病毒自检。logistic回归模型显示,是否使用过互联网(OR = 1.535, CI: [1.231, 1.9150], p < 0.05)、是否检测过艾滋病毒(OR = 0.181, CI: [0.122, 0.268], p < 0.001)、是否居住在农村(OR = 0.493, CI: [0.349, 0.698], p < 0.001)、所在地区(OR = 3.619, CI: [2.120, 6.178], p < 0.001)。结论:该研究证实hiv感染受多种社会人口因素的影响,呼吁采取有针对性的干预措施来改善男性hiv感染。
{"title":"Drivers of Utilization of HIV Self-Test Among Males in Malawi: A Multilevel Analysis of the Multiple Indicator Cluster Survey 2019-2020.","authors":"Thokozani Mzumara, Yamikani Matewere, Mayamiko Mbamba, Chisomo White, Aaron Chidothe, Lazarus Obed Livingstone Banda, Grace Ogbonna, George Munthali, Rita Soko, Mlotha Mbughi, James Mkandawire","doi":"10.1155/arat/5527525","DOIUrl":"10.1155/arat/5527525","url":null,"abstract":"<p><strong>Background: </strong>Implementation of health programs often overlooks males compared to females, and this is true even for HIV programs. Most men do not visit hospitals, and this is where, for example, most of the HIV services are delivered, including HIV testing. Self-testing can help men know their HIV status and possibly prevent the spread and increase treatment uptake.</p><p><strong>Aim: </strong>This study aimed to assess the utilization of HIV self-testing among males in Malawi and its predictors.</p><p><strong>Methods: </strong>This paper utilizes secondary quantitative data from the 2019-2020 Multiple Indicator Cluster Survey (MICS). The study sample included 7750 males aged 15 to 49. Data analysis used the Chi-square test to show the association between self-testing and rural/urban residence, region, radio-listenership, internet use, prior testing history, and educational level. Then, a multilevel binary logistic regression analysis was done to show the effect of predictor variables on the outcome reporting on the fixed and random effects, including the odds ratio, 95% confidence interval, and intraclass correlation coefficient. Statistical significance was determined at the <i>p</i> < 0.05 level.</p><p><strong>Results: </strong>Approximately 10% of males have ever used an HIV self-test. The logistic regression model indicated that ever used the internet (OR = 1.535, CI: [1.231, 1.9150], <i>p</i> < 0.05), ever tested for HIV (OR = 0.181, CI: [0.122, 0.268], <i>p</i> < 0.001), rural residence (OR = 0.493, CI: [0.349, 0.698], <i>p</i> < 0.001), and region (OR = 3.619, CI: [2.120, 6.178], <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>The study confirms that HIVST is affected by several sociodemographic factors, calling for targeted interventions to improve HIVST among males.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"5527525"},"PeriodicalIF":1.8,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12598098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABCB1 Polymorphism in HIV-Infected Individuals Taking Antiretroviral Drugs. 服用抗逆转录病毒药物的hiv感染者ABCB1多态性
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-10-16 eCollection Date: 2025-01-01 DOI: 10.1155/arat/9656615
HariOm Singh, Dharmesh Samani, Supriya D Mahajan

ABC transporter P-glycoprotein (P-gp) and its expression enhance elimination and reduce drug exposure. The elimination of non-nucleoside reverse-transcriptase inhibitor (NNRTIs) drugs is associated with ABCB1 gene. Drug exposure is impacted by variants in the ABCB1 gene. Hence, the aim of the study was to investigate the association of ABCB1 1236 C/T and 3435 C/T polymorphisms with the modulation of antiretroviral (ARV)-associated hepatotoxicity. This is a cross-sectional study. Genotyping of the ABCB1 1236C/T and 3435C/T polymorphisms was performed in 165 HIV-infected individuals (34 with hepatotoxicity and 131 without hepatotoxicity) and 155 healthy controls using the PCR-RFLP method. The TC haplotype was likely to be associated with a higher risk of severe hepatotoxicity (OR = 1.96, p = 0.06), while CC and TT haplotypes were associated with a reduced risk of severe hepatotoxicity (OR = 0.34, p = 0.039; OR = 0.16, p = 0.006; OR = 0.09, p = 0.003). The ABCB1 3435CT genotype along with alcohol usage revealed a risk of HIV disease progression (OR = 2.47, p = 0.12). The ABCB1 1236TT genotype along with nevirapine (NVP) usage exhibited a risk for hepatotoxicity severity (OR = 2.11, p = 0.55). The ABCB1 3435CT genotype along with alcohol + NVP usage bared a risk of acquisition of hepatotoxicity (OR = 2.04, p = 0.23). In conclusion, ABCB1 haplotypes may influence the severity of ARV-induced hepatotoxicity. While individual polymorphisms and their interaction with alcohol or drug regimen showed no significant association, the 1236TT genotype with NVP use and the TC haplotype suggested a potential risk. Protective effects were observed for CC and TT haplotypes. Larger studies are warranted to confirm these findings and assess clinical relevance.

ABC转运蛋白p -糖蛋白(P-gp)及其表达增强消除和减少药物暴露。非核苷类逆转录酶抑制剂(NNRTIs)药物的消除与ABCB1基因有关。药物暴露受ABCB1基因变异的影响。因此,本研究的目的是研究ABCB1 1236 C/T和3435 C/T多态性与抗逆转录病毒(ARV)相关肝毒性调节的关系。这是一项横断面研究。采用PCR-RFLP方法对165例hiv感染者(34例肝毒性,131例无肝毒性)和155例健康对照进行ABCB1 1236C/T和3435C/T多态性基因分型。TC单倍型可能与严重肝毒性的高风险相关(OR = 1.96, p = 0.06),而CC和TT单倍型与严重肝毒性的风险降低相关(OR = 0.34, p = 0.039; OR = 0.16, p = 0.006; OR = 0.09, p = 0.003)。ABCB1 3435CT基因型与酒精使用显示HIV疾病进展的风险(OR = 2.47, p = 0.12)。ABCB1 1236TT基因型与奈韦拉平(NVP)的使用显示出肝毒性严重程度的风险(OR = 2.11, p = 0.55)。ABCB1 3435CT基因型与酒精+ NVP的使用有获得肝毒性的风险(OR = 2.04, p = 0.23)。总之,ABCB1单倍型可能影响arv诱导的肝毒性的严重程度。虽然个体多态性及其与酒精或药物治疗方案的相互作用未显示出显著相关性,但1236TT基因型与NVP使用和TC单倍型提示存在潜在风险。CC和TT单倍型均有保护作用。需要更大规模的研究来证实这些发现并评估临床相关性。
{"title":"ABCB1 Polymorphism in HIV-Infected Individuals Taking Antiretroviral Drugs.","authors":"HariOm Singh, Dharmesh Samani, Supriya D Mahajan","doi":"10.1155/arat/9656615","DOIUrl":"10.1155/arat/9656615","url":null,"abstract":"<p><p>ABC transporter P-glycoprotein (P-gp) and its expression enhance elimination and reduce drug exposure. The elimination of non-nucleoside reverse-transcriptase inhibitor (NNRTIs) drugs is associated with <i>ABCB1</i> gene. Drug exposure is impacted by variants in the ABCB1 gene. Hence, the aim of the study was to investigate the association of <i>ABCB1</i> 1236 C/T and 3435 C/T polymorphisms with the modulation of antiretroviral (ARV)-associated hepatotoxicity. This is a cross-sectional study. Genotyping of the ABCB1 1236C/T and 3435C/T polymorphisms was performed in 165 HIV-infected individuals (34 with hepatotoxicity and 131 without hepatotoxicity) and 155 healthy controls using the PCR-RFLP method. The TC haplotype was likely to be associated with a higher risk of severe hepatotoxicity (OR = 1.96, <i>p</i> = 0.06), while CC and TT haplotypes were associated with a reduced risk of severe hepatotoxicity (OR = 0.34, <i>p</i> = 0.039; OR = 0.16, <i>p</i> = 0.006; OR = 0.09, <i>p</i> = 0.003). The <i>ABCB1</i> 3435CT genotype along with alcohol usage revealed a risk of HIV disease progression (OR = 2.47, <i>p</i> = 0.12). The <i>ABCB1</i> 1236TT genotype along with nevirapine (NVP) usage exhibited a risk for hepatotoxicity severity (OR = 2.11, <i>p</i> = 0.55). The <i>ABCB1</i> 3435CT genotype along with alcohol + NVP usage bared a risk of acquisition of hepatotoxicity (OR = 2.04, <i>p</i> = 0.23). In conclusion, ABCB1 haplotypes may influence the severity of ARV-induced hepatotoxicity. While individual polymorphisms and their interaction with alcohol or drug regimen showed no significant association, the 1236TT genotype with NVP use and the TC haplotype suggested a potential risk. Protective effects were observed for CC and TT haplotypes. Larger studies are warranted to confirm these findings and assess clinical relevance.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"9656615"},"PeriodicalIF":1.8,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, Attitudes, and Practices Regarding HIV/AIDS Among Adolescents in Internally Displaced Persons (IDP) Camps in Mogadishu, Somalia: A Descriptive Cross-Sectional Study. 索马里摩加迪沙境内流离失所者(IDP)营地中青少年关于艾滋病毒/艾滋病的知识、态度和做法:一项描述性横断面研究。
IF 1.8 Q4 INFECTIOUS DISEASES Pub Date : 2025-10-06 eCollection Date: 2025-01-01 DOI: 10.1155/arat/5911447
Najib Isse Dirie, Mulki Mukhtar Hassan, Amal Naleye Ali, Mohamed Mustaf Ahmed, Jaweriya Bashir Ahmed, Abdullahi Hassan Elmi, Hamza Mohamed Abdullahi, Liban Hassan Mohamed

Background: HIV/AIDS remains a major global health challenge worldwide. Adolescents, particularly those in displaced populations, are highly vulnerable to HIV infection. This study aimed to assess the knowledge, attitudes, and practices (KAP) regarding HIV/AIDS among adolescents in internally displaced persons (IDP) camps in Mogadishu, Somalia.

Methods: We conducted a descriptive cross-sectional study of adolescents aged 13-19 years living in IDP settlements in Mogadishu's Kahda and Deynile districts. Data were collected using a validated questionnaire. We constructed composite KAP indices using prespecified cutoff points, summarized outcomes descriptively, and compared groups by age and gender using χ 2 tests and one-way ANOVA, with ethical approval and assent/consent procedures in place.

Results: This study included 440 adolescents with a mean age of 15 ± 2 years, 68% of whom were female. The majority (69%) demonstrated poor knowledge of HIV/AIDS, with common misconceptions about transmission, such as 75% believing that mosquito bites and 85% believing that sharing meals could transmit HIV infection. Negative attitudes toward people living with HIV/AIDS were prevalent, with 84% displaying stigmatizing views. For instance, 81% believed that HIV-positive students should not attend school, and 89% were unwilling to buy vegetables from an HIV-positive vendor. HIV testing rates were extremely low at 0.45%, and only 2.1% of sexually active participants reported condom use. Participants were primarily from the Deynile and Kahda districts, with significant representation from the Southwest State and Hirshabelle. No significant differences in knowledge and attitude scores were observed between the sex or age groups.

Conclusion: Adolescents in IDP camps in Mogadishu demonstrated poor knowledge, stigmatizing attitudes, and risky HIV/AIDS practices. These findings highlight the urgent need for culturally sensitive educational programs, improved access to testing and counselling services, and community-based stigma reduction interventions for this vulnerable population.

背景:艾滋病毒/艾滋病仍然是世界范围内一项重大的全球卫生挑战。青少年,特别是流离失所人口中的青少年,极易感染艾滋病毒。本研究旨在评估索马里摩加迪沙境内流离失所者(IDP)营地中青少年关于艾滋病毒/艾滋病的知识、态度和做法(KAP)。方法:我们对生活在摩加迪沙Kahda和Deynile地区国内流离失所者定居点的13-19岁青少年进行了描述性横断面研究。使用有效的问卷收集数据。我们使用预先指定的截止点构建了复合KAP指数,描述性地总结了结果,并使用χ 2检验和单因素方差分析按年龄和性别进行了组间比较,并进行了伦理批准和同意/同意程序。结果:本研究纳入440例青少年,平均年龄15±2岁,其中68%为女性。大多数人(69%)表现出对艾滋病毒/艾滋病的了解不足,对传播有普遍的误解,例如75%的人认为蚊子叮咬会传播艾滋病毒,85%的人认为共用食物会传播艾滋病毒。对艾滋病毒/艾滋病感染者的负面态度普遍存在,84%的人表现出污名化的观点。例如,81%的人认为艾滋病毒阳性的学生不应该上学,89%的人不愿意从艾滋病毒阳性的小贩那里买蔬菜。艾滋病毒检测率极低,为0.45%,只有2.1%的性活跃参与者报告使用避孕套。参与者主要来自Deynile和Kahda地区,西南州和Hirshabelle地区也有大量代表。知识和态度得分在性别和年龄组之间无显著差异。结论:摩加迪沙境内流离失所者营地的青少年表现出知识贫乏、污名化的态度和危险的艾滋病毒/艾滋病行为。这些发现突出表明,迫切需要制定具有文化敏感性的教育计划,改善获得检测和咨询服务的机会,并为这一弱势群体提供基于社区的减少污名化干预措施。
{"title":"Knowledge, Attitudes, and Practices Regarding HIV/AIDS Among Adolescents in Internally Displaced Persons (IDP) Camps in Mogadishu, Somalia: A Descriptive Cross-Sectional Study.","authors":"Najib Isse Dirie, Mulki Mukhtar Hassan, Amal Naleye Ali, Mohamed Mustaf Ahmed, Jaweriya Bashir Ahmed, Abdullahi Hassan Elmi, Hamza Mohamed Abdullahi, Liban Hassan Mohamed","doi":"10.1155/arat/5911447","DOIUrl":"10.1155/arat/5911447","url":null,"abstract":"<p><strong>Background: </strong>HIV/AIDS remains a major global health challenge worldwide. Adolescents, particularly those in displaced populations, are highly vulnerable to HIV infection. This study aimed to assess the knowledge, attitudes, and practices (KAP) regarding HIV/AIDS among adolescents in internally displaced persons (IDP) camps in Mogadishu, Somalia.</p><p><strong>Methods: </strong>We conducted a descriptive cross-sectional study of adolescents aged 13-19 years living in IDP settlements in Mogadishu's Kahda and Deynile districts. Data were collected using a validated questionnaire. We constructed composite KAP indices using prespecified cutoff points, summarized outcomes descriptively, and compared groups by age and gender using <i>χ</i> <sup>2</sup> tests and one-way ANOVA, with ethical approval and assent/consent procedures in place.</p><p><strong>Results: </strong>This study included 440 adolescents with a mean age of 15 ± 2 years, 68% of whom were female. The majority (69%) demonstrated poor knowledge of HIV/AIDS, with common misconceptions about transmission, such as 75% believing that mosquito bites and 85% believing that sharing meals could transmit HIV infection. Negative attitudes toward people living with HIV/AIDS were prevalent, with 84% displaying stigmatizing views. For instance, 81% believed that HIV-positive students should not attend school, and 89% were unwilling to buy vegetables from an HIV-positive vendor. HIV testing rates were extremely low at 0.45%, and only 2.1% of sexually active participants reported condom use. Participants were primarily from the Deynile and Kahda districts, with significant representation from the Southwest State and Hirshabelle. No significant differences in knowledge and attitude scores were observed between the sex or age groups.</p><p><strong>Conclusion: </strong>Adolescents in IDP camps in Mogadishu demonstrated poor knowledge, stigmatizing attitudes, and risky HIV/AIDS practices. These findings highlight the urgent need for culturally sensitive educational programs, improved access to testing and counselling services, and community-based stigma reduction interventions for this vulnerable population.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2025 ","pages":"5911447"},"PeriodicalIF":1.8,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12517990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
AIDS Research and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1